Evidence map›Paper›PMID 26307342›Full record

ArticleScientific reports2015

Chemopreventive effects of Strobilanthes crispus leaf extract on azoxymethane-induced aberrant crypt foci in rat colon.

Nawal Al-Henhena, Shaden A M Khalifa, Rozaida Poh Yuen Ying, Pouya Hassandarvish, Elham Rouhollahi, Nahla Saeed Al-Wajeeh, Habibah Mohd Ali, Mahmood Ameen Abdulla, Hesham R El-Seedi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Nawal Al-HenhenaDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur , Malaysia.
Shaden A M KhalifaDepartment of Experimental Hematology, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.
Rozaida Poh Yuen YingDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur , Malaysia.
Pouya HassandarvishDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur , Malaysia.
Elham RouhollahiDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur , Malaysia.
Nahla Saeed Al-WajeehDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur , Malaysia.
Habibah Mohd AliDepartment of Chemistry, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Mahmood Ameen AbdullaDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur , Malaysia.
Hesham R El-SeediDepartment of Chemistry, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia.
University of Malaya · MYKarolinska University Hospital · SEUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, microscopic and histological studies suggest that Strobilanthes crispus ethanol extract reduce azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) in rats. S. crispus is considered a traditional medicine and used as an antioxidant. Its leaf contains a large amount of phenolic compounds to which its radical scavenging role is attributed and enhance its ability to eradicate oxidative stress reactions. The study was designed to determine the chemopreventive effect of S. crispus ethanol extract in vivo and in vitro by elucidating the effect of the extract on intermediate biomarkers which can be used as effective predictors of colon cancer. S. crispus was analyzed for DPPH free radical scavenging, nitric oxide (NO) and ferric acid reduction. The results indicated that S. crispus oral administration significantly inhibited colorectal carcinogenesis induced by AOM as revealed by the reduction in the number of ACF. S. crispus down-regulated the expression of PCNA, Bcl2 and β-catenin. Additionally, it exerted a pronounced inhibitory effect on MDA and NO levels and stimulatory effect on CAT and GPx activities. These results demonstrate that S. crispus is a chemopreventive agent for colorectal cancer through the suppression of early and intermediate carcinogenic phases that may be related to its flavonoid content.

Indexed as

AzoxymethaneAcanthaceaeAdministration, OralAnimalsAntioxidantsCarcinogensChemopreventionColonColonic PolypsDose-Response Relationship, DrugDrug InteractionsFemaleMalePlant ExtractsPlant LeavesRatsAntioxidantsAzoxymethaneCarcinogensPlant Extracts

Identifiers

PMID26307342
PMCPMC4642519
OpenAlexW1806390685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.